Vimarsana
Biggest News Aggregation in the World

Page 37 - Diagnostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Inc Today - Breaking & Trending Today

Global Clinical Trial Imaging Market Forecast to 2028 - - Vimarsana News

Global Clinical Trial Imaging Market Forecast to 2028 -

Dublin, July 11, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trial Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality,...

PanGenomic subsidiary begins health assessment service - Vimarsana News

PanGenomic subsidiary begins health assessment service

PanGenomic Health Inc - Vancouver, Canada-based precision health company - On Thursday says its subsidiary MUJN Diagnostics Inc has started a Vitamin D health assessment service. Additionally, says...

Critical Review: Co-Diagnostics (NASDAQ:CODX) and CellaVision AB (publ) (OTCMKTS:CLVSF) - Vimarsana News

Critical Review: Co-Diagnostics (NASDAQ:CODX) and CellaVision AB (publ) (OTCMKTS:CLVSF)

Co-Diagnostics (NASDAQ:CODX – Free Report) and CellaVision AB (publ) (OTCMKTS:CLVSF – Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Earnings and Valuation This table compares Co-Diagnostics and CellaVision AB […]

Head to Head Contrast: CellaVision AB (publ) (OTCMKTS:CLVSF) & Co-Diagnostics (NASDAQ:CODX) - Vimarsana News

Head to Head Contrast: CellaVision AB (publ) (OTCMKTS:CLVSF) & Co-Diagnostics (NASDAQ:CODX)

Co-Diagnostics (NASDAQ:CODX – Free Report) and CellaVision AB (publ) (OTCMKTS:CLVSF – Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for […]

Source: wkrb13.com
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - Vimarsana News

Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update

Lucid Diagnostics Inc. (NASDAQ:LUCD – Free Report) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 141,900 shares, a growth of 21.8% from the May 31st total of 116,500 shares. Based on an average daily volume of 65,800 shares, the short-interest ratio is […]